HOME >> MEDICINE >> NEWS
Tobacco chemical protects against Parkinson's disease

SAN FRANCISCO, March 27 -- For the first time, scientists have identified a chemical in tobacco that may explain why smokers are statistically less vulnerable to Parkinson's disease. The compound has been shown to slow the breakdown of key brain chemicals, including dopamine, which is typically depleted in the brains of patients with Parkinson's disease, according to researchers at Virginia Tech. The association between smoking and Parkinson's disease has been known for more than 20 years, but until now could not be scientifically explained.

The findings were presented here today at the 219th national meeting of the American Chemical Society, the world's largest scientific society, by Kay Castagnoli, a senior research associate in the Department of Chemistry and a member of the school's Harvey W. Peters Center for the Study of Parkinson's Disease.

The tobacco compound is described as a derivative of naphthoquinone, and works by interfering with an enzyme in the brain known as monoamine oxidase (MAO). MAO typically breaks down neurotransmitters - including dopamine, serotonin, and norepinephrine - as part of normal chemical activity in the brain.

In their study, the Virginia Tech researchers administered MPTP, a designer drug that produces a Parkinson-like disease, to laboratory rodents. Sold in the early l980s, MPTP was meant to mimic the effects of heroin. Addicts who took large doses suffered severe Parkinsonian symptoms. The naphthoquinone derivative protected the rodents against the toxic effects of MPTP, according to the researchers.

The researchers have started a second rodent study to confirm their initial findings. In addition, tests are underway in which the blood platelets of smokers are examined - before and after they smoke - to see if the naphthoquinone or related tobacco-derived compounds reduce MAO activity. The results will be correlated with the effects of the napththoquinone on MAO activ
'"/>

Contact: Charmayne Marsch
y_marsh@acs.org
202-872-4445
American Chemical Society
26-Mar-2000


Page: 1 2

Related medicine news :

1. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
2. Tobacco industry pays scientists to challenge secondhand smokes link to infant death risk
3. Exposed: Tobacco industrys efforts to cast doubt
4. Tobacco-company-sponsored parties with free cigarettes may encourage students to start smoking
5. Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO
6. Tobacco sponsorship of Formula One must stop, say health experts
7. UCI Tobacco research center reports why teens are most vulnerable to smoking addiction
8. Tobacco should be excluded from free trade agreement
9. Tobacco use common in schools demonstrating poor academic performance
10. Tobacco industry strategies for influencing European community tobacco advertising legislation
11. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... ... With many students either starting college for the first time, and returning to school, the ... CDC , “there are about 20 million new cases of STDs each year in the ... and 24. Young people are at greater risk of getting an STD.” To that end, ...
(Date:8/14/2019)... ... August 14, 2019 , ... Inc. magazine today revealed that RKC ... 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. With 200% ... and #153 in the Health sector. The list represents a unique look at the ...
(Date:8/14/2019)... , ... August 13, 2019 , ... ... joined the esteemed Haute Beauty network. , The Haute Beauty Network, well known ... Dr. Reyes-Bergano as a leading aesthetic medicine expert and our newest addition to ...
(Date:8/14/2019)... ... 14, 2019 , ... Today, consumers are taking a harder look at what ... body, emotions and energy levels. The trick is finding food and beverages that are ... why founder Chris Harper created Chase – a delicious, guilt free cocktail ...
(Date:8/12/2019)... ... August 12, 2019 , ... ... the $56,595,000 Series 2019A&B Bonds for Lesley University, which is currently rated A-/Stable ... 2019 Bonds will be used primarily to refund the outstanding debt on the ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... Quantum ... could potentially treat treatment-resistant hypertension by acting in the brain to interfere with ... people worldwide that are affected by treatment-resistant hypertension, resulting in almost 10 million ...
(Date:8/16/2019)... ... August 16, 2019 , ... OCT Clinical Trials ... has successfully completed enrollment of 690 patients for a phase III efficacy study ... randomized, double-blind, placebo-controlled, home use, parallel group clinical trial of MED2002, which is ...
(Date:8/14/2019)... ... August 14, 2019 , ... ... research and development of its drug platform GVT (Monosodium Luminol), created to treat ... disease among others. Overwhelming data from multiple animal studies have proven that GVT ...
Breaking Medicine Technology:
Cached News: